Skip to main content

ADVERTISEMENT

regurgitation

Original Contribution
11/04/2022

Stephanie Brunner;  Simon F. Stämpfli, MD, MSc;  Matthias Paul, MD;  Bart De Boeck, MD, PhD;  Mathias Wolfrum, MD;  Federico Moccetti, MD;  Adrian Attinger-Toller, MD;  Matthias Bossard, MD;  Florim Cuculi, MD;  Peter Matt, MD;  Richard Kobza, MD;  Stefan Toggweiler, MD

Stephanie Brunner;  Simon F. Stämpfli...
Patients with severe mitral regurgitation (MR) frequently present with concomitant right ventricular (RV) dysfunction and tricuspid regurgitation (TR). We aimed to investigate the prognostic relevance of RV function, RV dimension, and TR in...
Patients with severe mitral regurgitation (MR) frequently present with concomitant right ventricular (RV) dysfunction and tricuspid regurgitation (TR). We aimed to investigate the prognostic relevance of RV function, RV dimension, and TR in...
Patients with severe mitral...
11/04/2022
Journal of Invasive Cardiology
Original Contribution
03/30/2017

Julia Seeger, MD;  Patrick M√ºller;  Birgid Gonska, MD;  Dominik Scharnbeck, MD;  Sinisa Markovic, MD;  Daniel Walcher, MD;  Wolfgang Rottbauer, MD;  Jochen W√∂hrle, MD

Julia Seeger, MD;  Patrick M√ºller;  ...
This study compares early device success, procedural success, and 30-day safety endpoint according to the new Mitral Valve Academic Research Consortium criteria (MVARC) in severe primary and secondary mitral regurgitation (MR) patients.
This study compares early device success, procedural success, and 30-day safety endpoint according to the new Mitral Valve Academic Research Consortium criteria (MVARC) in severe primary and secondary mitral regurgitation (MR) patients.
This study compares early device...
03/30/2017
Journal of Invasive Cardiology